Neurology
RSSArticles
-
Tetrabenazine Tablets (Xenazine®)
The FDA has approved the first drug for the treatment of Huntington's disease. -
Full October 15, 2008 Issue in PDF
-
The Traveler in the ED: Common Presentations
Regardless of where we practice, increasingly we are confronted with patients who have been exposed to unusual diseases through travel. In a previous series of articles, we reviewed the diseases associated with travel, largely based on the geography. This article reviews infectious disease associated with travel by symptoms. -
Full October 13, 2008 Issue in PDF
-
Epilepsy and Sleep Apnea
Obstructive sleep apnea may be both a cause and a consequence of uncontrolled epileptic seizures. -
Chronic Migraine: Recognition, Prevention, and Treatment
Increased migraine attack frequency and overuse of acute medication, especially barbiturates and opiates, are risk factors for the chronification of migraine, which occurs in up to 2% of individuals. -
How the Cerebellum Affects Dystonia
Two animal models of dystonia reveal that cerebellar activity influences abnormal involuntary dystonic movements, and implicate dysfunction of a cerebellar-striatal network in the development of dystonia. -
Clinical Briefs in Primary Care supplement
-
Full October 1, 2008 Issue in PDF
-
Monitoring Response to Antiplatelet Therapy: A Role in Neurointerventional Procedures?
Platelet function testing identifies patients who do not respond to antiplatelet therapy and are at increased risk for acute stent thrombosis after neurointerventional procedures.